The store will not work correctly when cookies are disabled.
3-[(10-Oxo-9,10-dihydroanthracene-9-ylidene)amino]benzoicacid
ID: ALA2283227
PubChem CID: 76312780
Max Phase: Preclinical
Molecular Formula: C21H13NO3
Molecular Weight: 327.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1cccc(N=C2c3ccccc3C(=O)c3ccccc32)c1
Standard InChI: InChI=1S/C21H13NO3/c23-20-17-10-3-1-8-15(17)19(16-9-2-4-11-18(16)20)22-14-7-5-6-13(12-14)21(24)25/h1-12H,(H,24,25)
Standard InChI Key: KWPAMLOKAOOOLJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
17.3129 -8.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3118 -9.7855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0314 -10.2029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7484 -9.7850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7456 -8.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0296 -8.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4633 -8.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4601 -7.7043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5978 -8.5406 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1793 -8.9451 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5976 -7.7149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6070 -6.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3203 -6.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3160 -7.3043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0272 -7.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7431 -7.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7434 -6.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0316 -6.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8867 -7.3028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8905 -6.4705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1798 -6.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4648 -6.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4650 -7.2947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1764 -7.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6115 -5.2383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
1 9 1 0
7 10 1 0
9 11 2 0
11 14 1 0
11 19 1 0
13 12 1 0
12 20 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
12 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.34 | Molecular Weight (Monoisotopic): 327.0895 | AlogP: 4.10 | #Rotatable Bonds: 2 |
Polar Surface Area: 66.73 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.59 | CX Basic pKa: 0.74 | CX LogP: 4.74 | CX LogD: 2.00 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.60 | Np Likeness Score: -0.35 |
References
1. Bansal SK, Sinha BN, Khosa RL. (2013) -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation, 22 (1): [10.1007/s00044-012-0023-0] |